These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 33423422)

  • 1. Acne fulminans induced by a low dose isotretinoin: case report and review of the literature.
    Fakih A; Goens J; Grozdev I; Dangoisse C; Richert B
    Dermatol Online J; 2020 Dec; 26(12):. PubMed ID: 33423422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acne fulminans and isotretinoin: case report.
    Pereira MF; Roncada EM; Oliveira CM; Monteiro R; Abreu MA; Ortigosa LC
    An Bras Dermatol; 2011; 86(5):983-5. PubMed ID: 22147039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pseudo-acne fulminans associated with oral isotretinoin.
    Grando LR; Leite OG; Cestari TF
    An Bras Dermatol; 2014; 89(4):657-9. PubMed ID: 25054758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isotretinoin-triggered acne fulminans: a rare, disabling occurrence.
    Gualtieri B; Panduri S; Chiricozzi A; Romanelli M
    G Ital Dermatol Venereol; 2020 Jun; 155(3):361-362. PubMed ID: 30229637
    [No Abstract]   [Full Text] [Related]  

  • 5. Acne fulminans following isotretinoin therapy.
    Didona D; Paolino G; Cantisani C; Viti G; Caposiena Caro DR; Didona B
    G Ital Dermatol Venereol; 2019 Feb; 154(1):84-85. PubMed ID: 28712269
    [No Abstract]   [Full Text] [Related]  

  • 6. Isotretinoin-induced acne fulminans without systemic symptoms with concurrent exuberant granulation tissue.
    Li AW; Antaya RJ
    Pediatr Dermatol; 2018 Mar; 35(2):257-258. PubMed ID: 29314240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe acne fulminans following low-dose isotretinoin and testosterone use.
    Barańska-Rybak W; Mehrholz D; Flis P; Karpinsky G; Sokołowska-Wojdyło M
    Cutis; 2019 Jun; 103(6):E20-E21. PubMed ID: 31348466
    [No Abstract]   [Full Text] [Related]  

  • 8. Acute myopathy and acne fulminans triggered by isotretinoin therapy.
    Sarifakioglu E; Onur O; Kart H; Yilmaz AE
    Eur J Dermatol; 2011; 21(5):794-5. PubMed ID: 21727056
    [No Abstract]   [Full Text] [Related]  

  • 9. Isotretinoin-induced Acne Fulminans without Systemic Symptoms Treated Successfully with Oral Dapsone.
    Legal K; Misery L
    Acta Derm Venereol; 2020 Jan; 100(1):adv00036. PubMed ID: 31626323
    [No Abstract]   [Full Text] [Related]  

  • 10. Sacroiliitis after use of oral isotretinoin--association with acne fulminans or adverse effect?
    Geller AS; Alagia RF
    An Bras Dermatol; 2013; 88(6 Suppl 1):193-6. PubMed ID: 24346917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unilateral sacroiliitis associated with systemic isotretinoin treatment.
    Barbareschi M; Paresce E; Chiaratti A; Ferla Lodigiani A; Clerici G; Greppi F
    Int J Dermatol; 2010 Mar; 49(3):331-3. PubMed ID: 20465675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acne fulminans triggered by isotretinoin therapy].
    Joly P; Prost C; Gaudemar M; Revuz J
    Ann Dermatol Venereol; 1991; 118(5):369-72. PubMed ID: 1832826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acne in the first three decades of life: An update of a disorder with profound implications for all decades of life.
    Greydanus DE; Azmeh R; Cabral MD; Dickson CA; Patel DR
    Dis Mon; 2021 Apr; 67(4):101103. PubMed ID: 33041056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acne fulminans and erythema nodosum during isotretinoin therapy responding to dapsone.
    Tan BB; Lear JT; Smith AG
    Clin Exp Dermatol; 1997 Jan; 22(1):26-7. PubMed ID: 9330049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disabling acne fulminans.
    Zanelato TP; Gontijo GM; Alves CA; Pinto JC; Cunha PR
    An Bras Dermatol; 2011; 86(4 Suppl 1):S9-12. PubMed ID: 22068759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the efficacies of intermittent and continuous low-dose isotretinoin regimens in the treatment of moderate acne vulgaris.
    Boyraz N; Mustak PK
    Int J Dermatol; 2013 Oct; 52(10):1265-7. PubMed ID: 23675954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effectiveness of intermittent isotretinoin treatment in mild or moderate acne.
    Kaymak Y; Ilter N
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1256-60. PubMed ID: 17062042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disfiguring ulcerative neutrophilic dermatosis secondary to doxycycline and isotretinoin in an adolescent boy with acne conglobata.
    Sotoodian B; Kuzel P; Brassard A; Fiorillo L
    Cutis; 2017 Dec; 100(6):E23-E26. PubMed ID: 29360905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isotretinoin updates.
    On SC; Zeichner J
    Dermatol Ther; 2013; 26(5):377-89. PubMed ID: 24099068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SAPHO syndrome: the supposed trigger by isotretinoin, the efficacy of adalimumab and the specter of depressive disorder: a case report.
    Luzzati M; Simonini G; Filippeschi C; Giani T; Trapani S
    Ital J Pediatr; 2020 Nov; 46(1):169. PubMed ID: 33187546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.